Aprea Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Aprea Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Aprea Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $14.7M, a 186% increase year-over-year.
  • Aprea Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $5.14M, a 653% increase from 2022.
  • Aprea Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $683K, a 60.9% decline from 2021.
  • Aprea Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $1.75M, a 1057% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.14M +$4.46M +653% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $683K -$1.06M -60.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $1.75M +$1.6M +1057% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-26
2020 $151K -$92.4M -99.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-30
2019 $92.6M +$36.2M +64.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 $56.4M +$33M +141% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-16
2017 $23.3M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.